- Open Access
Correction to: Diabetes, cardiovascular disease and the microcirculation
Cardiovascular Diabetology volume 20, Article number: 120 (2021)
Correction to: Cardiovasc Diabetol (2018) 17:57 https://doi.org/10.1186/s12933-018–0703-2
The authors suggested deleting the following statement in section ‘The effect of anti‑diabetes drugs on microcirculation’ from the original publication, citing the retracted article. The overall conclusions of the review article are not affected by this erratum.
“In addition to anti-diabetes agents, statins were reported to improve endothelial dysfunction and microvascular reactivity in patients with T2DM and dyslipidaemia, suggesting positive outcomes on CV morbidity and mortality of these class of drugs .”
Furthermore, the affiliation of author Päivi Maria Paldánius has changed since the original publication. The updated affiliations are provided with this erratum.
Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17:57. https://doi.org/10.1186/s12933-018-0703-2.
Kim KM, Jung KY, Yun HM, Lee SY, Oh TJ, Jang HC, Lim S. Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report. Cardiovasc Diabetol. 2017;16(1):146. https://doi.org/10.1186/s12933-017-0629-0.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Strain, W.D., Paldánius, P.M. Correction to: Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol 20, 120 (2021). https://doi.org/10.1186/s12933-021-01307-5